Gold
Compare Stocks
4 / 10Stock Comparison
DRD vs LIN vs APD vs AU
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Gold
DRD vs LIN vs APD vs AU — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Gold | Chemicals - Specialty | Chemicals - Specialty | Gold |
| Market Cap | $2.47B | $228.85B | $65.68B | $50.58B |
| Revenue (TTM) | $15.96B | $34.66B | $12.46B | $10.38B |
| Net Income (TTM) | $4.82B | $7.13B | $2.11B | $2.86B |
| Gross Margin | 40.3% | 46.0% | 32.0% | 47.8% |
| Operating Margin | 25.1% | 28.8% | 18.4% | 45.5% |
| Forward P/E | 0.6x | 27.7x | 22.5x | 9.2x |
| Total Debt | $17M | $26.99B | $18.41B | $2.44B |
| Cash & Equiv. | $1.31B | $5.06B | $1.86B | $2.93B |
DRD vs LIN vs APD vs AU — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DRDGOLD Limited (DRD) | 100 | 292.4 | +192.4% |
| Linde plc (LIN) | 100 | 244.1 | +144.1% |
| Air Products and Ch… (APD) | 100 | 122.1 | +22.1% |
| AngloGold Ashanti P… (AU) | 100 | 407.9 | +307.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DRD vs LIN vs APD vs AU
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DRD is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.52, Low D/E 0.2%, current ratio 2.28x
- 30.2% margin vs APD's 16.9%
- 32.9% ROA vs APD's 5.1%, ROIC 9.8% vs -2.0%
LIN is the clearest fit if your priority is stability.
- Beta 0.24 vs AU's 0.79
APD is the clearest fit if your priority is income & stability.
- Dividend streak 29 yrs, beta 0.45, yield 2.4%
AU carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 70.8%, EPS growth 122.7%, 3Y rev CAGR 30.0%
- 6.5% 10Y total return vs DRD's 5.5%
- PEG 0.54 vs LIN's 1.09
- Beta 0.79, yield 3.7%, current ratio 2.87x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 70.8% revenue growth vs APD's -0.5% | |
| Value | Lower P/E (9.2x vs 22.5x) | |
| Quality / Margins | 30.2% margin vs APD's 16.9% | |
| Stability / Safety | Beta 0.24 vs AU's 0.79 | |
| Dividends | 3.7% yield, 2-year raise streak, vs APD's 2.4% | |
| Momentum (1Y) | +137.5% vs LIN's +11.2% | |
| Efficiency (ROA) | 32.9% ROA vs APD's 5.1%, ROIC 9.8% vs -2.0% |
DRD vs LIN vs APD vs AU — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DRD vs LIN vs APD vs AU — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AU leads in 3 of 6 categories
DRD leads 1 • LIN leads 0 • APD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AU leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 3.3x AU's $10.4B. DRD is the more profitable business, keeping 30.2% of every revenue dollar as net income compared to APD's 16.9%. On growth, AU holds the edge at +75.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $16.0B | $34.7B | $12.5B | $10.4B |
| EBITDAEarnings before interest/tax | $4.9B | $12.1B | $3.9B | $4.8B |
| Net IncomeAfter-tax profit | $4.8B | $7.1B | $2.1B | $2.9B |
| Free Cash FlowCash after capex | $1.1B | $5.1B | $1.1B | $3.4B |
| Gross MarginGross profit ÷ Revenue | +40.3% | +46.0% | +32.0% | +47.8% |
| Operating MarginEBIT ÷ Revenue | +25.1% | +28.8% | +18.4% | +45.5% |
| Net MarginNet income ÷ Revenue | +30.2% | +20.6% | +16.9% | +27.6% |
| FCF MarginFCF ÷ Revenue | +6.8% | +14.7% | +8.9% | +32.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +26.6% | +8.2% | +8.8% | +75.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +89.0% | +13.4% | +141.1% | +63.1% |
Valuation Metrics
AU leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 18.1x trailing earnings, DRD trades at a 47% valuation discount to LIN's 33.8x P/E. Adjusting for growth (PEG ratio), AU offers better value at 1.12x vs LIN's 1.33x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.5B | $228.8B | $65.7B | $50.6B |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $250.8B | $82.2B | $50.1B |
| Trailing P/EPrice ÷ TTM EPS | 18.07x | 33.85x | -166.67x | 19.30x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.61x | 27.67x | 22.46x | 9.25x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.33x | — | 1.12x |
| EV / EBITDAEnterprise value multiple | 28.50x | 19.75x | 119.66x | 9.14x |
| Price / SalesMarket cap ÷ Revenue | 5.14x | 6.73x | 5.46x | 5.11x |
| Price / BookPrice ÷ Book value/share | 4.57x | 5.82x | 3.79x | 5.13x |
| Price / FCFMarket cap ÷ FCF | 32.24x | 44.97x | — | 16.29x |
Profitability & Efficiency
DRD leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DRD delivers a 44.8% return on equity — every $100 of shareholder capital generates $45 in annual profit, vs $12 for APD. DRD carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to APD's 1.06x. On the Piotroski fundamental quality scale (0–9), AU scores 8/9 vs APD's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +44.8% | +17.8% | +11.9% | +30.8% |
| ROA (TTM)Return on assets | +32.9% | +8.3% | +5.1% | +20.3% |
| ROICReturn on invested capital | +9.8% | +11.3% | -2.0% | +35.9% |
| ROCEReturn on capital employed | +9.3% | +13.0% | -2.4% | +35.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 2 | 8 |
| Debt / EquityFinancial leverage | 0.00x | 0.68x | 1.06x | 0.25x |
| Net DebtTotal debt minus cash | -$1.3B | $21.9B | $16.6B | -$492M |
| Cash & Equiv.Liquid assets | $1.3B | $5.1B | $1.9B | $2.9B |
| Total DebtShort + long-term debt | $17M | $27.0B | $18.4B | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | 274.61x | 34.52x | 12.00x | 21.64x |
Total Returns (Dividends Reinvested)
AU leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AU five years ago would be worth $45,696 today (with dividends reinvested), compared to $11,324 for APD. Over the past 12 months, AU leads with a +137.5% total return vs LIN's +11.2%. The 3-year compound annual growth rate (CAGR) favors AU at 54.8% vs APD's 2.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.7% | +15.5% | +19.2% | +19.1% |
| 1-Year ReturnPast 12 months | +91.2% | +11.2% | +14.2% | +137.5% |
| 3-Year ReturnCumulative with dividends | +123.5% | +39.7% | +7.0% | +271.1% |
| 5-Year ReturnCumulative with dividends | +180.8% | +73.9% | +13.2% | +357.0% |
| 10-Year ReturnCumulative with dividends | +546.6% | +375.2% | +166.4% | +653.9% |
| CAGR (3Y)Annualised 3-year return | +30.7% | +11.8% | +2.3% | +54.8% |
Risk & Volatility
Evenly matched — LIN and APD each lead in 1 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than AU's 0.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APD currently trades 96.0% from its 52-week high vs DRD's 72.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.52x | 0.24x | 0.45x | 0.79x |
| 52-Week HighHighest price in past year | $39.37 | $521.28 | $307.29 | $129.14 |
| 52-Week LowLowest price in past year | $12.75 | $387.78 | $229.11 | $38.61 |
| % of 52W HighCurrent price vs 52-week peak | +72.6% | +94.7% | +96.0% | +77.6% |
| RSI (14)Momentum oscillator 0–100 | 50.3 | 51.7 | 55.0 | 50.5 |
| Avg Volume (50D)Average daily shares traded | 309K | 2.3M | 1.2M | 2.7M |
Analyst Outlook
Evenly matched — APD and AU each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DRD as "Buy", LIN as "Buy", APD as "Buy", AU as "Buy". Consensus price targets imply 62.8% upside for DRD (target: $47) vs 6.0% for APD (target: $313). For income investors, AU offers the higher dividend yield at 3.68% vs DRD's 1.06%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $46.50 | $539.71 | $312.78 | $133.00 |
| # AnalystsCovering analysts | 5 | 28 | 42 | 14 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +1.2% | +2.4% | +3.7% |
| Dividend StreakConsecutive years of raises | 0 | 6 | 29 | 2 |
| Dividend / ShareAnnual DPS | $4.97 | $6.00 | $7.11 | $3.68 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% | 0.0% | 0.0% |
AU leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). DRD leads in 1 (Profitability & Efficiency). 2 tied.
DRD vs LIN vs APD vs AU: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DRD or LIN or APD or AU a better buy right now?
For growth investors, AngloGold Ashanti Plc (AU) is the stronger pick with 70.
8% revenue growth year-over-year, versus -0. 5% for Air Products and Chemicals, Inc. (APD). DRDGOLD Limited (DRD) offers the better valuation at 18. 1x trailing P/E (0. 6x forward), making it the more compelling value choice. Analysts rate DRDGOLD Limited (DRD) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DRD or LIN or APD or AU?
On trailing P/E, DRDGOLD Limited (DRD) is the cheapest at 18.
1x versus Linde plc at 33. 8x. On forward P/E, DRDGOLD Limited is actually cheaper at 0. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AngloGold Ashanti Plc wins at 0. 54x versus Linde plc's 1. 09x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DRD or LIN or APD or AU?
Over the past 5 years, AngloGold Ashanti Plc (AU) delivered a total return of +357.
0%, compared to +13. 2% for Air Products and Chemicals, Inc. (APD). Over 10 years, the gap is even starker: AU returned +653. 9% versus APD's +166. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DRD or LIN or APD or AU?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus AngloGold Ashanti Plc's 0. 79β — meaning AU is approximately 227% more volatile than LIN relative to the S&P 500. On balance sheet safety, DRDGOLD Limited (DRD) carries a lower debt/equity ratio of 0% versus 106% for Air Products and Chemicals, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DRD or LIN or APD or AU?
By revenue growth (latest reported year), AngloGold Ashanti Plc (AU) is pulling ahead at 70.
8% versus -0. 5% for Air Products and Chemicals, Inc. (APD). On earnings-per-share growth, the picture is similar: AngloGold Ashanti Plc grew EPS 122. 7% year-over-year, compared to -110. 3% for Air Products and Chemicals, Inc.. Over a 3-year CAGR, AU leads at 30. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DRD or LIN or APD or AU?
DRDGOLD Limited (DRD) is the more profitable company, earning 28.
5% net margin versus -3. 3% for Air Products and Chemicals, Inc. — meaning it keeps 28. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AU leads at 45. 1% versus -7. 3% for APD. At the gross margin level — before operating expenses — AU leads at 46. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DRD or LIN or APD or AU more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, AngloGold Ashanti Plc (AU) is the more undervalued stock at a PEG of 0. 54x versus Linde plc's 1. 09x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, DRDGOLD Limited (DRD) trades at 0. 6x forward P/E versus 27. 7x for Linde plc — 27. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DRD: 62. 8% to $46. 50.
08Which pays a better dividend — DRD or LIN or APD or AU?
All stocks in this comparison pay dividends.
AngloGold Ashanti Plc (AU) offers the highest yield at 3. 7%, versus 1. 1% for DRDGOLD Limited (DRD).
09Is DRD or LIN or APD or AU better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +375. 2% 10Y return). Both have compounded well over 10 years (LIN: +375. 2%, APD: +166. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DRD and LIN and APD and AU?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DRD is a small-cap high-growth stock; LIN is a large-cap quality compounder stock; APD is a mid-cap quality compounder stock; AU is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.